GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Medico Intercontinental Ltd

Medico Intercontinental Q2 FY27 Standalone Net Profit at Rs. 60.34 Lakhs

RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 06 Nov 2026, 01:45 PM IST  ·  BSE ID: 3a58e501-ff8e-4245-8f1b-4b49c4b27c74
View Original BSE Filing (PDF)
💡
In Simple Terms
Medico Intercontinental reported a standalone profit of Rs. 60.34 Lakhs for the last quarter, while consolidating a net loss of Rs. (56.42) Lakhs.
🤖 AI Summary
  • Standalone net profit for Q2 FY27 was Rs. 60.34 Lakhs for the quarter ended September 30, 2026.
  • Total standalone revenue from operations reached Rs. 114.05 Lakhs in Q2 FY27.
  • Consolidated net loss for Q2 FY27 stood at Rs. (56.42) Lakhs for the period.
  • Consolidated total revenue for the quarter was Rs. 1504.66 Lakhs, including subsidiaries and a joint venture.
  • The Board of Directors approved unaudited standalone and consolidated financial results on November 06, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Standalone Total Revenue (Q2 FY27)
Rs. 114.05 Lakhs
Standalone Profit/(Loss) for the period (After tax) (Q2 FY27)
Rs. 60.34 Lakhs
Consolidated Total Revenues (Q2 FY27)
Rs. 1504.66 Lakhs
Consolidated Net Profit (Loss) for the period (Q2 FY27)
Rs. (56.42) Lakhs
Standalone Earnings Per Equity Share (Basic) (Q2 FY27)
Rs. 0.61
🏢 How This Affects the Company
💰
Financial Impact
The company recorded a standalone net profit of Rs. 60.34 Lakhs and a consolidated net loss of Rs. (56.42) Lakhs for Q2 FY27. Total standalone revenue for the quarter was Rs. 114.05 Lakhs, while consolidated total revenue was Rs. 1504.66 Lakhs.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, observing the standalone net profit of Rs. 60.34 Lakhs and consolidated net loss of Rs. (56.42) Lakhs.
🔍
Management Signal
Management approved both standalone and consolidated unaudited financial results, indicating disclosure of the company's and group's performance for Q2 FY27.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results — monitor consolidated profitability trends.
Future filings — observe performance of subsidiaries and joint venture.
Board Meeting outcomes — any further strategic financial decisions.
MEDIUM RISK Consolidated net loss indicates group-level financial challenges despite standalone profit, requiring careful monitoring.
💡 Investor Takeaway
Medico Intercontinental reported standalone net profit of Rs. 60.34 Lakhs and standalone total revenue of Rs. 114.05 Lakhs for Q2 FY27. The company recorded a consolidated net loss of Rs. (56.42) Lakhs for the quarter ended September 30, 2026, with consolidated total revenue of Rs. 1504.66 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Standalone Net Profit for Q2 FY27 was Rs. 60.34 Lakhs, showing a positive quarterly standalone earning.
  • Standalone Total Revenue from Operations reached Rs. 114.05 Lakhs in Q2 FY27.

⚠️ Concerns

  • Consolidated Net Loss for Q2 FY27 was Rs. (56.42) Lakhs, indicating losses at the group level.
  • Consolidated Total Revenue of subsidiaries and joint venture not reviewed by auditors was Rs. 1504.66 Lakhs, reflecting a significant portion of the group revenue.
📅 Company Track Record
Medico Intercontinental reported Q1 FY27 standalone net profit of Rs. 60.76 Lakhs (up 9.28% YoY) in its previous financial results filing on August 14, 2026. This shows a slight decrease in standalone net profit in Q2 FY27 compared to Q1 FY27.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Medico Intercontinental's standalone net profit in Q2 FY27?
Medico Intercontinental's standalone net profit for the quarter ended September 30, 2026 (Q2 FY27) was Rs. 60.34 Lakhs.
What were Medico Intercontinental's total standalone revenues in Q2 FY27?
Total standalone revenue from operations for Medico Intercontinental in Q2 FY27 was Rs. 114.05 Lakhs.
What was Medico Intercontinental's consolidated net profit or loss in Q2 FY27?
Medico Intercontinental reported a consolidated net loss of Rs. (56.42) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What were Medico Intercontinental's consolidated total revenues in Q2 FY27?
Consolidated total revenues for Medico Intercontinental in Q2 FY27 were Rs. 1504.66 Lakhs.
When did the Board of Directors approve these Q2 FY27 results?
The Board of Directors of Medico Intercontinental Limited approved the unaudited standalone and consolidated financial results for Q2 FY27 on November 06, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.